NCT01795859 - First Time Use of SD-809 in Huntington Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 5, 2013

Primary Completion Date

December 5, 2014

Study Completion Date

December 5, 2014

Conditions

Chorea

Interventions

DRUG

SD-809

SD-809 tablets are available in three dose strengths: 6, 9 and 12 mg, all of which are identical in size, shape and color (white).

DRUG

Placebo

Placebo tablets are identical in appearance to SD-809 tablets.

Trial Locations (43)

Unknown

Teva Investigational Site 057, Birmingham

Teva Investigational Site 038, Phoenix

Teva Investigational Site 298, Fayetteville

Teva Investigational Site 050, Los Angeles

Teva Investigational Site 052, Englewood

Teva Investigational Site 333, Washington D.C.

Teva Investigational Site 196, Boca Raton

Teva Investigational Site 160, Gainesville

Teva Investigational Site 014, Miami

Teva Investigational Site 032, Atlanta

Teva Investigational Site 045, Indianapolis

Teva Investigational Site 024, Iowa City

Teva Investigational Site 029, Kansas City

Teva Investigational Site 083, Wichita

Teva Investigational Site 087, Louisville

Teva Investigational Site 028, Baltimore

Teva Investigational Site 040, Boston

Teva Investigational Site 027, St Louis

Teva Investigational Site 194, Las Vegas

Teva Investigational Site 328, Camden

Teva Investigational Site 026, New Brunswick

Teva Investigational Site 037, Albany

Teva Investigational Site 002, New York

Teva Investigational Site 342, Patchogue

Teva Investigational Site 119, Durham

Teva Investigational Site 089, Cincinnati

Teva Investigational Site 020, Columbus

Teva Investigational Site 093, Toledo

Teva Investigational Site 341, Tulsa

Teva Investigational Site 031, Nashville

Teva Investigational Site 007, Houston

Teva Investigational Site 199, Houston

Teva Investigational Site 100, Salt Lake City

Teva Investigational Site 137, Burlington

Teva Investigational Site 220, Kirkland

Teva Investigational Site 096, Seattle

Teva Investigational Site 104, Milwaukee

Teva Investigational Site 144, Kew Vic

Teva Investigational Site 054, Sydney

Teva Investigational Site 098, Montreal

Teva Investigational Site 300, North York

Teva Investigational Site 231, Ottawa

Teva Investigational Site 300, Ottawa

All Listed Sponsors

lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY